InvestorsHub Logo
Followers 45
Posts 1566
Boards Moderated 1
Alias Born 02/13/2006

Re: Bob-C post# 601

Saturday, 07/28/2012 11:46:08 PM

Saturday, July 28, 2012 11:46:08 PM

Post# of 6242
MMStockPlay, I plan to hold STEM into earnings on Monday, July 30, 2012. Based on the current CIRM (California Institute for Regenerative Medicine) grant of $20M to STEM and the next potential grant of $20M to STEM from CIRM for Alzheimer's research on September 6, 2012 the future for STEM and STEM's PPS is looking good.

Please see my STEM charts at your convenience. As an educated guesstimate and not trading or investment advice, the STEM charts seem to point to $4-$6 in the IT to LT.

StemCells announced initiation of a Phase I/II clinical trial of the company's proprietary HuCNS-SC product candidate - purified human neural stem cells - in dry age-related macular degeneration, or AMD, referred to as Geographic Atrophy. There are no approved treatments for dry AMD. :theflyonthewall




I will be watching for any price rise in STEM along with any potential large increase in volume either on the upside or the downside. If in the ensuing days STEM rises above $4 along with heavy distribution and/or short-selling volume I may take my profits and run and reinvest later at a lower PPS.

Cheers, :)

Bob

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.